REGN

#239
Regeneron Pharmaceuticals, Inc. - Common Stock
614.7 8 USD
-1.08%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
613.35
614.78
Intervallo Annuale
476.48
821.11
Variazione giornaliera
-1.08%
Variazione Mensile
-11.30%
Variazione di 6 mesi
-20.77%
Variazione Annuale
+19.14%
Chiusura Precedente
621.5 2
Open
614.3 3
Minimo
613.3 5
High
614.7 8
Volume
432
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 64.45 B
  • Employee 15 K
  • Founded 1988
  • CEO Leonard Schleifer
  • Website www.regeneron.com
  • Headquarter New York, United States
  • FIGI BBG000C734W3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
18.61
Rapporto prezzo/fatturato
5.84

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Notizie